Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Latin American Cooperative Oncology Group (LACOG) is a non-profit organization dedicated to the development and management of clinical and epidemiological research in oncology across Latin America. Founded in 2009, it is the first cooperative group in the region to focus on multi-center cancer studies, aiming to improve cancer care and outcomes through high-quality scientific evidence. LACOG operates a vast network of over 200 investigators and 100 institutions across 16 countries, collaborating with international research groups and pharmaceutical companies. Their work spans various cancer types, including breast, lung, and genitourinary cancers, providing critical data on regional patient populations. The organization provides a robust infrastructure for conducting Phase 1 through Phase 4 clinical trials, ensuring adherence to international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LACOG.